Circulating Tumor Cells Market

The Circulating Tumor Cells (CTC) market encompasses technologies for detecting and analyzing cancer cells that have detached from a tumor and entered the bloodstream. The primary customers are hospitals, clinics, diagnostic centers, and research institutes using this technology for non-invasive cancer diagnosis and monitoring. Key growth drivers include the rising global prevalence of cancer, increasing demand for personalized medicine, and significant advancements in liquid biopsy technologies.